We are live on ! Find out more
AZNH

AstraZeneca
AZNH

Delisted

AZNH was delisted on the 29th of January, 2026.

Back to rankings

1 hedge funds and large institutions have $2.09M invested in AstraZeneca in 2025 Q2 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

28.41% less ownership

Funds ownership: 79.32% → 50.91% (-28%)

43% less capital invested

Capital invested by funds: $3.63M → $2.09M (-$1.55M)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$1.2M

AZNH Hedge Fund Activity: Q2 2025 in Review

1 of the 7,617 institutional investors tracked by Wall St. Rank reported a position in AstraZeneca (AZNH) for Q2 2025, worth a combined $2.09M — down 43% from $3.63M a quarter earlier.

Fund positioning in AZNH was balanced in Q2 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $1.2M.

  • 1 institutional investor held AstraZeneca (AZNH) as of Q2 2025, unchanged from Q1 2025.
  • Funds reported $2.09M of AstraZeneca stock for Q2 2025, down 43% quarter-over-quarter.
  • 0 funds opened new AstraZeneca positions in Q2 2025 and 0 closed out.
  • The largest AstraZeneca seller in Q2 2025 was Citadel Advisors, an estimated $1.2M sold.

Based on aggregated 13F filings for Q2 2025.